학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 762건 | 목록 1~20
Academic Journal
Knikman JE; Div. of Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Dept. of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; de With M; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands; Dept. of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Heersche N; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands; Dept. of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Lopez-Yurda M; Biometrics Dept., The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Baars A; Dept. of Medical Oncology, Hospital Gelderse Vallei, Ede, the Netherlands.; Creemers GJ; Dept. of Medical Oncology, Catharina Hospital, Eindhoven, the Netherlands.; Droogendijk HJ; Dept. of Internal Medicine, Bravis Hospital, Roosendaal, the Netherlands.; Fiets E; Dept. of Internal Medicine, Medical Centre Leeuwarden, Leeuwarden, the Netherlands.; Imholz ALT; Dept. of Internal Medicine, Deventer Hospital, Deventer, the Netherlands.; Iersel LV; Dept. of Internal Medicine, Division of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands.; Mandigers CMPW; Dept. of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands.; van de Vendel AJ; Dept. of Medical Oncology, Hospital Gelderse Vallei, Ede, the Netherlands.; Jeurissen FJF; Dept. of Internal Medicine, Haaglanden Medical Centre, The Hague, the Netherlands.; Nieboer P; Dept. of Internal Medicine, Wilhelmina Hospital Assen, Assen, the Netherlands.; Deenen MJ; Dept. of Clinical Pharmacy, Catharina Hospital, Eindhoven, the Netherlands; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; van de Poel MHW; Dept. of Internal Medicine, Laurentius Hospital, Roermond, the Netherlands.; Wymenga MNM; Dept. of Internal Medicine, Medisch Spectrum Twente, Enschede, the Netherlands.; van Schaik RHN; Dept. of Clinical Chemistry, Erasmus University Medical Centre, Rotterdam, the Netherlands.; van den Bosch BJC; Dept. Of Clinical Genetics, Maastricht University Medical Centre, Maastricht, the Netherlands.; Hoop EO; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Rosing H; Dept. of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Swen JJ; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; Gelderblom H; Dept. of Medical Oncology, Leiden University Medical Centre, Leiden, the Netherlands.; Schellens JHM; Dept. of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Beijnen JH; Dept. of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Div. of Pharmacoepidemiology and Clinical Pharmacology, Dept. of Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, the Netherlands.; Guchelaar HJ; Dept. of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, the Netherlands.; Cats A; Dept. of Gastrointestinal Oncology, Div. of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: a.cats@nki.nl.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
Academic Journal
Voogd DWM; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Lucassen MJJ; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. me.lucassen@nki.nl.; van der Noll R; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zielhuis SWJ; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Boss D; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Tibben M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Schellens JHM; Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Utrecht Institute of Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, The Netherlands.; Steeghs N; Department of Medical Oncology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
Publisher: Adis Country of Publication: New Zealand NLM ID: 101677510 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2366-1089 (Electronic) Linking ISSN: 23661089 NLM ISO Abbreviation: Oncol Ther Subsets: PubMed not MEDLINE
Academic Journal
Knikman JE; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Lopez-Yurda M; Biometrics Department, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK.; Deenen MJ; Department of Clinical Pharmacy, Catharina Hospital, Eindhoven, The Netherlands.; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.; Schellens JHM; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Beijnen J; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Cats A; Division of Medical Oncology, Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Centre, Leiden, The Netherlands.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Rollema H; BioPharmaWorks LLC, 93, Shennecossett Rd, Groton, CT 06340, USA. Electronic address: hans.rollema@gmail.com.; Volkmann R; BioPharmaWorks LLC, 93, Shennecossett Rd, Groton, CT 06340, USA.; Zagouras P; BioPharmaWorks LLC, 93, Shennecossett Rd, Groton, CT 06340, USA.; Nelson F; BioPharmaWorks LLC, 93, Shennecossett Rd, Groton, CT 06340, USA.; Braish T; BioPharmaWorks LLC, 93, Shennecossett Rd, Groton, CT 06340, USA.; Marfat A; BioPharmaWorks LLC, 93, Shennecossett Rd, Groton, CT 06340, USA.; Schellens JHM; Lixte Biotechnology Holdings, Inc., 680, E Colorado Blvd Suite 180, Pasadena, CA 91101, USA. Electronic address: jschellens@lixte.com.; Kovach JS; Lixte Biotechnology Holdings, Inc., 680, E Colorado Blvd Suite 180, Pasadena, CA 91101, USA.
Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE
Editorial & Opinion
de With M; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.; Knikman J; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Schellens JHM; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Cats A; Division of Medical Oncology, Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Leiden Network for Personalised Therapeutics (LNPT), Leiden, The Netherlands.; Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Leiden Network for Personalised Therapeutics (LNPT), Leiden, The Netherlands.; Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
de With M; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.; Knikman J; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; de Man FM; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Lunenburg CATC; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Henricks LM; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.; van Kuilenburg ABP; Laboratory Genetic Metabolic Diseases, Department of Clinical Chemistry, Amsterdam UMC, Cancer Center Amsterdam, Amsterdam Gastroenterology Endocrinology Metabolism, University of Amsterdam, Amsterdam, The Netherlands.; Maring JG; Department of Pharmacy, Isala Hospital, Zwolle, The Netherlands.; Isala Diaconessen Hospital, Meppel, The Netherlands.; van Staveren MC; Department of Clinical Pharmacy and Toxicology, Treant Healthgroup, Scheper Hospital, Emmen, The Netherlands.; de Vries N; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Pluim D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Modak A; Cambridge Isotope Laboratories, Tewksbury, Massachusetts, USA.; Imholz ALT; Department of Internal Medicine, Deventer Hospital, Deventer, The Netherlands.; van Schaik RHN; Department of Clinical Chemistry, Erasmus Medical Center, Rotterdam, The Netherlands.; Schellens JHM; Division of Pharmacoepidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Cats A; Division of Medical Oncology, Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Leiden Network for Personalised Therapeutics (LNPT), Leiden, The Netherlands.; Mathijssen RHJ; Department of Medical Oncology, Erasmus Medical Center Cancer Institute, Rotterdam, The Netherlands.; Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Leiden Network for Personalised Therapeutics (LNPT), Leiden, The Netherlands.; Meulendijks D; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Medical Oncology, Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Late Development Oncology, AstraZeneca, Cambridge, UK.
Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Academic Journal
Knikman JE; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Zhai Q; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Lunenburg CATC; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Henricks LM; Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.; Böhringer S; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; Department of Biomedical Data Sciences, Leiden University Medical Center, Leiden, The Netherlands.; van der Lee M; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.; de Man FM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Offer SM; Department of Pathology, Carver College of Medicine, University of Iowa, Iowa City, IA, USA.; Holden Comprehensive Cancer Center, University of Iowa, Iowa City, IA, USA.; Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.; Shrestha S; Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Creemers GJ; Department of Medical Oncology, Catharina Hospital, Eindhoven, The Netherlands.; Baars A; Department of Internal Medicine, Hospital Gelderse Vallei, Ede, The Netherlands.; Dezentjé VO; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands.; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Imholz ALT; Department of Internal Medicine, Deventer Hospital, Deventer, The Netherlands.; Jeurissen FJF; Department of Internal Medicine, Haaglanden Medical Center, The Hague, The Netherlands.; Portielje JEA; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Jansen RLH; Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands.; Hamberg P; Department of Internal Medicine, Franciscus Gasthuis en Vlietland, Rotterdam, The Netherlands.; Droogendijk HJ; Department of Internal Medicine, Bravis Hospital, Roosendaal, The Netherlands.; Koopman M; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Nieboer P; Department of Internal Medicine, Wilhelmina Hospital Assen, Assen, The Netherlands.; van de Poel MHW; Department of Internal Medicine, Laurentius Hospital, Roermond, The Netherlands.; Mandigers CMPW; Department of Internal Medicine, Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.; van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, Netherlands.; Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.; Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Schellens JHM; Department of Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Cats A; Department of Gastroenterology and Hepatology, Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Guchelaar HJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands. h.j.guchelaar@lumc.nl.; Swen JJ; Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
Publisher: BioMed Central Country of Publication: England NLM ID: 101475844 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-994X (Electronic) Linking ISSN: 1756994X NLM ISO Abbreviation: Genome Med Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Schellens, Jan H M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어